...
search icon
rna-img

Avidity Biosciences Inc Share Price

RNA
NMQ
$72.74
+$0.17
(0.23%)
1D
Industry: Biotechnology Sector: Health Care

Avidity Biosciences Inc Analyst Forecast

Avidity Biosciences Inc Share Price Chart

Avidity Biosciences Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$10.93B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.40M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.96
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$21.51 L
$72.74 H
$72.74

About Avidity Biosciences Inc, Common Stock

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs). Its AOC platform is designed to combine the specificity of monoclonal antibodies with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with such therapeutics. The company's pipeline has three programs in registrational clinical trials, such as Delpacibart etedesiran, which is in Phase 3 development stage for the treatment of people with myotonic dystrophy type 1; Delpacibart braxlosiran that is in Phase 1/2 development stage for treating facioscapulohumeral muscular dystrophy; and Delpacibart zotadirsen, which is in the Phase 2 EXPLORE44 open-label extension study for the treatment of Duchenne muscular dystrophy. The company is also developing precision cardiology candidates targeting rare genetic cardiomyopathies, including AOC 1086 for phospholamban cardiomyopathy and AOC 1072 for protein kinase AMP-activated non-catalytic subunit gamma 2 syndrome. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California. more

Industry: BiotechnologySector: Health Care

Avidity Biosciences Inc Stock Returns

Time FrameRNASectorS&P500
1-Week Return0.15%-2.13%-0.14%
1-Month Return0.89%-0.5%1.26%
3-Month Return4.21%7.12%1.27%
6-Month Return94.8%16.34%9.67%
1-Year Return127.6%4.95%15.74%
3-Year Return200.08%16.28%66.14%
5-Year Return225.6%33.63%81.39%
10-Year Return155.23%135.85%264.87%

Avidity Biosciences Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue6.79M9.33M9.22M9.56M10.90M[{"date":"2020-12-31","value":62.28,"profit":true},{"date":"2021-12-31","value":85.58,"profit":true},{"date":"2022-12-31","value":84.65,"profit":true},{"date":"2023-12-31","value":87.73,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue37.60M639.00K1.39M2.10M2.78M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":1.7,"profit":true},{"date":"2022-12-31","value":3.69,"profit":true},{"date":"2023-12-31","value":5.59,"profit":true},{"date":"2024-12-31","value":7.38,"profit":true}]
Gross Profit6.79M9.33M9.22M7.46M10.90M[{"date":"2020-12-31","value":62.28,"profit":true},{"date":"2021-12-31","value":85.58,"profit":true},{"date":"2022-12-31","value":84.65,"profit":true},{"date":"2023-12-31","value":68.45,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin100.00%100.00%100.00%78.02%100.00%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":78.02,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses51.06M127.38M188.14M243.06M389.83M[{"date":"2020-12-31","value":13.1,"profit":true},{"date":"2021-12-31","value":32.67,"profit":true},{"date":"2022-12-31","value":48.26,"profit":true},{"date":"2023-12-31","value":62.35,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(44.28M)(118.05M)(178.91M)(235.60M)(378.94M)[{"date":"2020-12-31","value":-4427700000,"profit":false},{"date":"2021-12-31","value":-11805100000,"profit":false},{"date":"2022-12-31","value":-17891300000,"profit":false},{"date":"2023-12-31","value":-23559800000,"profit":false},{"date":"2024-12-31","value":-37893600000,"profit":false}]
Total Non-Operating Income/Expense(81.00K)146.00K9.89M43.72M113.52M[{"date":"2020-12-31","value":-0.07,"profit":false},{"date":"2021-12-31","value":0.13,"profit":true},{"date":"2022-12-31","value":8.72,"profit":true},{"date":"2023-12-31","value":38.51,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(44.35M)(118.01M)(174.00M)(212.22M)(322.30M)[{"date":"2020-12-31","value":-4435500000,"profit":false},{"date":"2021-12-31","value":-11800900000,"profit":false},{"date":"2022-12-31","value":-17399500000,"profit":false},{"date":"2023-12-31","value":-21222000000,"profit":false},{"date":"2024-12-31","value":-32230200000,"profit":false}]
Income Taxes(373.00K)(639.00K)(4.92M)1.93M-[{"date":"2020-12-31","value":-19.3,"profit":false},{"date":"2021-12-31","value":-33.06,"profit":false},{"date":"2022-12-31","value":-254.41,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(43.98M)(117.37M)(169.08M)(214.15M)-[{"date":"2020-12-31","value":-4398200000,"profit":false},{"date":"2021-12-31","value":-11737000000,"profit":false},{"date":"2022-12-31","value":-16907700000,"profit":false},{"date":"2023-12-31","value":-21415310500,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(44.35M)(118.01M)(174.00M)(202.25M)(322.30M)[{"date":"2020-12-31","value":-4435500000,"profit":false},{"date":"2021-12-31","value":-11800900000,"profit":false},{"date":"2022-12-31","value":-17399500000,"profit":false},{"date":"2023-12-31","value":-20224800000,"profit":false},{"date":"2024-12-31","value":-32230200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(43.98M)(117.37M)(169.08M)(212.22M)(322.30M)[{"date":"2020-12-31","value":-4398200000,"profit":false},{"date":"2021-12-31","value":-11737000000,"profit":false},{"date":"2022-12-31","value":-16907700000,"profit":false},{"date":"2023-12-31","value":-21222000000,"profit":false},{"date":"2024-12-31","value":-32230200000,"profit":false}]
EPS (Diluted)(2.85)(2.84)(3.33)(2.90)(2.89)[{"date":"2020-12-31","value":-285,"profit":false},{"date":"2021-12-31","value":-284,"profit":false},{"date":"2022-12-31","value":-333,"profit":false},{"date":"2023-12-31","value":-290,"profit":false},{"date":"2024-12-31","value":-289,"profit":false}]

Avidity Biosciences Inc Ratios

Avidity Biosciences Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

RNA
Cash Ratio 11.04
Current Ratio 11.57

Avidity Biosciences Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

RNA
ROA (LTM) -20.28%
ROE (LTM) -32.44%

Avidity Biosciences Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

RNA
Debt Ratio Lower is generally better. Negative is bad. 0.12
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.88

Avidity Biosciences Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

RNA
Trailing PE NM
Forward PE NM
P/S (TTM) 523.99
P/B 5.80
Price/FCF NM
EV/R 436.56
EV/Ebitda NM
PEG NM

FAQs

What is Avidity Biosciences Inc share price today?

Avidity Biosciences Inc (RNA) share price today is $72.74

Can Indians buy Avidity Biosciences Inc shares?

Yes, Indians can buy shares of Avidity Biosciences Inc (RNA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RNA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Avidity Biosciences Inc be purchased?

Yes, you can purchase fractional shares of Avidity Biosciences Inc (RNA) via the Vested app. You can start investing in Avidity Biosciences Inc (RNA) with a minimum investment of $1.

How to invest in Avidity Biosciences Inc shares from India?

You can invest in shares of Avidity Biosciences Inc (RNA) via Vested in three simple steps:

  • Click on Sign Up or Invest in RNA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Avidity Biosciences Inc shares
What is Avidity Biosciences Inc 52-week high and low stock price?

The 52-week high price of Avidity Biosciences Inc (RNA) is $72.74. The 52-week low price of Avidity Biosciences Inc (RNA) is $21.51.

What is Avidity Biosciences Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Avidity Biosciences Inc (RNA) is

What is Avidity Biosciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Avidity Biosciences Inc (RNA) is 5.80

What is Avidity Biosciences Inc dividend yield?

The dividend yield of Avidity Biosciences Inc (RNA) is 0.00%

What is the Market Cap of Avidity Biosciences Inc?

The market capitalization of Avidity Biosciences Inc (RNA) is $10.93B

What is Avidity Biosciences Inc's stock symbol?

The stock symbol (or ticker) of Avidity Biosciences Inc is RNA

How Can Investors Use Avidity Biosciences Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Avidity Biosciences Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Avidity Biosciences Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Avidity Biosciences Inc shares for Indian investors?

When investing in Avidity Biosciences Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Avidity Biosciences Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Avidity Biosciences Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Avidity Biosciences Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Avidity Biosciences Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top